EMF Research File — The Landmark Studies

Interphone: The WHO’s 13-Country Brain Tumor Study and What the Heavy-User Data Actually Showed

The Interphone Study Group, 2010 — International Journal of Epidemiology — WHO/IARC coordinated

“There were suggestions of an increased risk of glioma, and much less so meningioma, in the highest decile of cumulative call time, in subjects who reported that their usual phone was on the same side as their tumour.” — Interphone Study Group, 2010

Study type: International case-control study coordinated by IARC/WHO
Coverage: 13 countries, 5,117 glioma cases + 5,634 controls; 2,765 meningioma cases + 2,993 controls
Years: Recruitment 2000–2004; publication 2010
Key finding: Elevated glioma risk in heaviest users (>1,640 lifetime hours); ipsilateral tumor predominance

What Interphone Actually Found (Beyond the Headlines)

The Interphone study is most often reported as “finding no overall increased risk” — and this is technically accurate for the overall population analysis. But the Interphone data is more nuanced, and the finding that matters is in the highest usage group.

Elevated glioma risk in highest decile of cumulative use. In the 10% of participants with the highest cumulative phone use (>1,640 hours over the study period), there was a statistically significant increased risk of glioma. This is the dose-response signal that matters: no elevation in average users, elevated risk in heaviest users.

Ipsilateral dominance in the high-use group. The elevated risk was concentrated in ipsilateral tumors — gliomas on the same side of the head as habitual phone use. This anatomical specificity is consistent with Hardell’s data and provides biological plausibility for the exposure-tumor location relationship.

Protective effect in low users (paradox). The overall Interphone data showed an apparent “protective effect” of phone use in low and medium users. This is widely interpreted as a methodological artifact (the “healthy user” bias in this specific study design) rather than a real biological protection. The artifact actually suppresses the overall risk estimate and obscures the high-user signal.

Why the overall “no risk” headline is misleading: Interphone defined “regular user” as using a phone at least once per week for six months — a definition that includes people who barely use their phones. The highest usage group (1,640+ lifetime hours) showed elevated risk that was statistically significant. The study’s own authors noted methodological limitations including recall bias and the “healthy user” effect that could mask a positive association in overall analysis.

What Interphone Tells Us About Dose and Latency

Interphone’s finding that heavy users (1,640+ lifetime hours) showed elevated glioma risk while average users showed none provides the dose-response context for current exposure patterns. Today’s average smartphone user accumulates far more than 1,640 hours per decade. The Interphone “heavy users” of 2000–2004 are today’s moderate users. This underscores why precautionary field modulation — not waiting for the next generation of heavy-user data — is the rational response. Explore the Aires research corpus →

The Interphone “heavy users” had 1,640 hours of cumulative use. Today’s average user passes that threshold in months.

Shop Aires Products →

Frequently Asked Questions

Did the Interphone study find that cell phones cause brain tumors?

The Interphone study found no overall increased risk across the full study population, but found a statistically significant increased glioma risk in the 10% of participants with the highest cumulative use (>1,640 lifetime hours). The elevated risk was stronger for ipsilateral tumors (on the same side as phone use). The study’s authors noted methodological limitations that could suppress an underlying positive association in the overall analysis.

Why does the Interphone “no risk” headline get so much media coverage?

The overall Interphone finding of no statistically significant risk across all users is technically accurate and easily summarized as a headline. The heavy-user subgroup finding, the ipsilateral tumor finding, and the methodological concerns are more complex and require engagement with the actual data. Industry communications and some media outlets have consistently emphasized the overall headline over the heavy-user finding.

How does Interphone compare to the Hardell studies?

Both Interphone and the Hardell studies are large case-control epidemiological studies of mobile phone use and brain tumors. The key difference is that Hardell has tracked longer latency periods (25+ years of use) while Interphone recruited participants with shorter maximum latency. Both found elevated risk in high-usage groups with ipsilateral tumor predominance. Hardell’s longer follow-up shows the risk signal becoming stronger over time.

What is the significance of the protective effect in low users?

The apparent “protective effect” of low phone use in Interphone is widely considered a study artifact. It likely reflects the “healthy user” bias: people who use phones very rarely may do so because they are unwell, while active phone users may be healthier on other lifestyle dimensions. The Interphone study design couldn’t fully control for this confound. The protective effect in low users is not replicated in other studies and is not considered a real biological finding.

The EMF Landmark Research Series

→ Full series overview: The EMF Research You Need to Know

Interphone: The WHO's 13-Country Brain Tumor Study and What the Heavy-User Data Actually Showed